Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Utility of Drug-eluting Stents in Complex Lesions and High-risk Patients.

Utility of Drug-eluting Stents in Complex Lesions and High-risk Patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Utility of Drug-eluting Stents in Complex Lesions and High-risk Patients. Abstract Text:

    eugenia nikolskyEugenia Nikolsky,gregg w stoneGregg W Stone,

    Drug-eluting stents represent a breakthrough technology designed to deliver high concentrations of a bioactive agent locally to an atherosclerotic lesion, thereby minimizing systemic side effects of the drug. The safety and efficacy of drug-eluting stents have clearly been demonstrated in noncomplex lesions. This article presents an evidence-based analysis of the current experience with CYPHER sirolimus-eluting stents (Cordis Corp., Miami Lakes, FL) and TAXUS paclitaxel-eluting stents (Boston Scientific, Natick, MA) in a broad spectrum of high-risk and/or complex subsets of patients and lesions, including those with diabetes mellitus, multivessel disease, diffuse disease, very small vessels, lesions in saphenous vein grafts, chronic total occlusions, in-stent restenosis, ostial and bifurcation lesions, unprotected left main disease, and acute myocardial infarction. Emerging data in several of these subsets suggest that drug-eluting stents are safe and effective, and their use may currently be recommended, whereas in other groups of patients and lesions the efficacy and/or safety of drug-eluting stents remains to be determined, thus warranting caution. It is anticipated that penetration of drug-eluting stents will continue to increase, and fewer patients will require surgical revascularization to achieve sustained event-free survival.

    Utility of Drug-eluting Stents in Complex Lesions and High-risk Patients. Publishing Authors By Initials

    e nikolskyE Nikolsky,gw stoneGW Stone,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Utility of Drug-eluting Stents in Complex Lesions and High-risk Patients. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Current treatment options in cardiovascular medici

    VOLUME: 9

    Page Numbers: 11-28

    Journal Abbreviation:

    ISSN: 1092-8464

    DAY: 23

    MONTH: Feb

    YEAR: 2007

    Utility of Drug-eluting Stents in Complex Lesions and High-risk Patients. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9815942

    Utility of Drug-eluting Stents in Complex Lesions and High-risk Patients. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Utility of Drug-eluting Stents in Complex Lesions and High-risk Patients. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Utility of Drug-eluting Stents in Complex Lesions and High-risk Patients.

    AFFILIATION: Gregg W. Stone, MD Columbia University Medical Center, Herbert Irving Pavilion, 5th Floor, 161 Fort Washington Avenue, New York, NY 10032, USA. gs2184@columbia.edu.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Curr Treat Options Cardiovasc

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Utility of Drug-eluting Stents in Complex Lesions and High-risk Patients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News